Nath Bio-Genes (India) Limited (NSE:NATHBIOGEN)
India flag India · Delayed Price · Currency is INR
148.00
-2.92 (-1.93%)
Feb 13, 2026, 3:29 PM IST

Nath Bio-Genes (India) Ratios and Metrics

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Feb '26 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
2,8172,7723,3082,6844,0555,705
Market Cap Growth
-11.24%-16.20%23.22%-33.79%-28.93%121.88%
Enterprise Value
4,3574,0264,2833,8364,8106,296
Last Close Price
148.21144.18170.54136.92204.18285.65
PE Ratio
6.537.188.357.67-10.25
PS Ratio
0.630.760.990.891.461.86
PB Ratio
0.410.430.540.470.750.93
P/TBV Ratio
0.420.440.550.480.770.95
P/FCF Ratio
-28.696.927.57--
P/OCF Ratio
-15.774.437.0023.78512.63
EV/Sales Ratio
0.981.101.291.271.732.05
EV/EBITDA Ratio
8.817.918.567.8512.789.38
EV/EBIT Ratio
9.638.549.168.3613.929.79
EV/FCF Ratio
-41.678.9610.81--
Debt / Equity Ratio
0.230.190.180.180.170.16
Debt / EBITDA Ratio
3.132.412.212.152.471.50
Debt / FCF Ratio
-12.682.312.97--
Net Debt / Equity Ratio
0.230.050.050.120.160.12
Net Debt / EBITDA Ratio
3.120.660.661.382.361.07
Net Debt / FCF Ratio
-3.480.691.89-22.44-6.86
Asset Turnover
-0.380.400.390.360.41
Inventory Turnover
-0.320.410.380.420.46
Quick Ratio
-0.510.680.660.500.84
Current Ratio
-1.892.182.402.413.10
Return on Equity (ROE)
-6.16%6.70%6.28%-11.67%9.51%
Return on Assets (ROA)
-3.09%3.49%3.74%2.83%5.29%
Return on Invested Capital (ROIC)
5.10%6.79%6.95%6.99%5.26%9.78%
Return on Capital Employed (ROCE)
-7.10%7.60%8.00%6.30%10.40%
Earnings Yield
15.31%13.93%11.98%13.04%-16.62%9.76%
FCF Yield
-3.49%14.46%13.22%-0.98%-1.83%
Dividend Yield
1.35%1.39%1.17%1.46%0.98%0.70%
Payout Ratio
8.81%9.85%9.59%10.86%--
Buyback Yield / Dilution
0.82%-----
Total Shareholder Return
2.17%1.39%1.17%1.46%0.98%0.70%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.